 |
|
Controlled Comparisons of Clomipramine and Fluoxetine in the Treatment of Obsessive-Compulsive DisorderBehavioral and Biological Results
Teresa A. Pigott, MD;
Michele T. Pato, MD;
Suzanne E. Bernstein;
Gay N. Grover, RN, MSN;
James L. Hill, PhD;
Teresa J. Tolliver, MBA;
Dennis L. Murphy, MD
Arch Gen Psychiatry. 1990;47(10):926-932.
Abstract
| |
• Treatment with fluoxetine hydrochloride was compared with treatment with clomipramine hydrochloride in two groups of patients with obsessive-compulsive disorder using two different experimental designs. In the first group of 11 patients with obsessive-compulsive disorder studied using a randomized, doubleblind, crossover design, treatment with fluoxetine for 10 weeks was found to produce therapeutic effects similar to treatment with clomipramine for 10 weeks. There were significantly fewer total side effects reported during fluoxetine than clomipramine treatment. Drug tapering and placebo substitution in the 4-week crossover interval phase led to substantial relapses in obsessive-compulsive disorder symptoms and depression. Furthermore, responses to the second drug took as long to occur as responses to the first drug, although both drugs are thought to act by a common mechanism, serotonin uptake inhibition. A second group of 21 patients with obsessive-compulsive disorder that had been previously stabilized on clomipramine treatmen with at least partial benefit were crossed over to fluoxetine treat ment in a double-blind fashion. After 10 weeks of fluoxetine administration, most patients manifested behavioral rating scores of obsessive-compulsive disorder and depressive symp toms that were comparable with precrossover ratings complete during clomipramine treatment. A significant exacerbation ir obsessive-compulsive disorder and depression ratings as wel as a similar lag in therapeutic efficacy were also noted in this second cohort of patients with obsessive-compulsive disorder Platelet 5-HT concentrations were reduced 95% during both clo mipramine and fluoxetine treatment periods. These results sug gest that fluoxetine may represent a viable alternative to clomip ramine in the treatment of obsessive-compulsive disorder, al though further studies with larger sample sizes are needed.
Author Affiliations
From the Laboratory of Clinical Science (Drs Pigott, Pato, Hill, and Murphy, and Mss Bernstein and Tolliver), and the Nursing Department (Ms Grover), National Institute of Mental Health, Bethesda, Md.
Footnotes
Accepted for publication June 5, 1990.
Reprint requests to Laboratory of Clinical Science, National Institute of Mental Health, National Institutes of Health Clinical Center, 10-3D41, 9000 Rockville Pike, Bethesda, MD 20892 (Dr Pigott).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
A novel, putative gain-of-function haplotype at SLC6A4 associates with obsessive-compulsive disorder
Wendland et al.
Hum Mol Genet 2008;17:717-723.
ABSTRACT
| FULL TEXT
Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine
Coleiro et al.
Rheumatology (Oxford) 2001;40:1038-1043.
ABSTRACT
| FULL TEXT
Multicenter Double-blind Comparison of Sertraline and Desipramine for Concurrent Obsessive-Compulsive and Major Depressive Disorders
Hoehn-Saric et al.
Arch Gen Psychiatry 2000;57:76-82.
ABSTRACT
| FULL TEXT
Selective serotonin reuptake inhibitors in obsessive-compulsive disorder
DTB 1995;33:47-48.
ABSTRACT
| FULL TEXT
Double-blind Parallel Comparison of Three Dosages of Sertraline and Placebo in Outpatients With Obsessive-compulsive Disorder
Greist et al.
Arch Gen Psychiatry 1995;52:289-295.
ABSTRACT
Efficacy and Tolerability of Serotonin Transport Inhibitors in Obsessive-compulsive Disorder: A Meta-analysis
Greist et al.
Arch Gen Psychiatry 1995;52:53-60.
ABSTRACT
Fluoxetine
Gram
NEJM 1994;331:1354-1361.
FULL TEXT
A Multicenter Investigation of Fixed-Dose Fluoxetine in the Treatment of Obsessive-compulsive Disorder
Tollefson et al.
Arch Gen Psychiatry 1994;51:559-567.
ABSTRACT
Tryptophan Depletion in Patients With Obsessive-Compulsive Disorder Who Respond to Serotonin Reuptake Inhibitors
Barr et al.
Arch Gen Psychiatry 1994;51:309-317.
ABSTRACT
Progress in Psychiatry- Second of Two Parts
Michels and Marzuk
NEJM 1993;329:628-638.
FULL TEXT
Case of Fluoxetine-Induced Remission of Raynaud's Phenomenon--A Case Report
Bolte and Avery
ANGIOLOGY 1993;44:161-163.
ABSTRACT
Caudate Glucose Metabolic Rate Changes With Both Drug and Behavior Therapy for Obsessive-Compulsive Disorder
Baxter et al.
Arch Gen Psychiatry 1992;49:681-689.
ABSTRACT
Psychodermatology: Practical Guidelines on Pharmacotherapy
Koo and Pham
Arch Dermatol 1992;128:381-388.
ABSTRACT
Are Effective Antiobsessional Drugs Interchangeable?
Tamimi and Mavissakalian
Arch Gen Psychiatry 1991;48:857-858.
ABSTRACT
|
